Dalbavancin to Complete a Prolonged Antibiotic Course for Persistent Bacillus cereus Bacteremia: A Case Report and Literature Review
Abstract
Bacillus cereus is a Gram-positive, rod-shaped facultative anaerobe commonly associated with gastrointestinal infections. Although typically regarded as a blood culture contaminant, B. cereus can cause severe infections, including bacteremia, in high-risk patients. We report a case of a 39-year-old male with a history of intravenous drug use (IVDU) presenting with fevers and found to have B. cereus bacteremia. Cultures remained persistently positive for B. cereus despite 7 days of therapeutic vancomycin. Gentamicin was initiated for Gram-positive synergistic effect with vancomycin. This combination of gentamicin and vancomycin resulted in blood culture clearance. On discharge, he received one dose of dalbavancin and oral levofloxacin for 21 days to complete a total 4-week antibiotic course from date of blood culture clearance. This case demonstrates that dalbavancin may be a promising alternative to standard treatments for prolonged antibiotic courses of B. cereus infections, particularly when intravenous access is a challenge.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.